Alibaba Health Information Technology Limited (ALBBY)
USD 8.67
(0.0%)
USD 8.67
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.07 Billion | 255.69 Million | 424.36 Million | 1 Billion | 583.61 Million | 396.37 Million |
| Net Income | 939.39 Million | 550.99 Million | -252.51 Million | 401.21 Million | 9.09 Million | -60.83 Million |
| Depreciation & Amortization | 53.68 Million | 63.71 Million | 60.57 Million | 39.62 Million | 41.68 Million | 3.98 Million |
| Deferred income taxes | - | 203.29 Million | -259.6 Million | 40.13 Million | 55.99 Million | -31.19 Million |
| Stock-based compensation | 266.05 Million | 308.89 Million | 408.09 Million | 396.95 Million | 277.13 Million | 213.49 Million |
| Change in working capital | -337.51 Million | -568.13 Million | 671.12 Million | 294.64 Million | 233.94 Million | 268 Million |
| Other non-cash items | -462.87 Million | -303.07 Million | -203.31 Million | -163.15 Million | -34.24 Million | 2.91 Million |
| Investing Cash Flow | -4.88 Billion | -532.43 Million | 1.87 Billion | -4.96 Billion | 1.34 Billion | -2.39 Billion |
| Investments in PPE | -22.78 Million | -5.92 Million | -15.11 Million | -17.55 Million | -13.51 Million | -6.1 Million |
| Acquisitions | -31.77 Million | -70.62 Million | -875.29 Million | -286.18 Million | -18.8 Million | -999.22 Million |
| Investment purchases | -5.36 Billion | -519.18 Million | -355 Million | -4.44 Billion | 5.94 Million | -2.27 Billion |
| Sales/Maturities of investments | 412.19 Million | 47.18 Million | 3.21 Billion | 25.38 Million | 1.35 Billion | 888.77 Million |
| Other Investing Activities | 13.39 Million | 16.11 Million | -96.33 Million | -234.09 Million | 14.71 Million | -3.61 Million |
| Financing Cash Flow | -1.98 Billion | -111.27 Million | -58.62 Million | 8.92 Billion | 328.81 Million | 1.7 Billion |
| Debt repayment | -39.93 Million | -42.58 Million | -47.01 Million | -31.61 Million | -1.7 Billion | -604.16 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -104.56 Million | -81.58 Million | -16.51 Million | -39.58 Million | -17.81 Million | -37.84 Million |
| Common Stock Issuance | 878 Thousand | 12.89 Million | 9.69 Million | 8.99 Billion | 2.11 Billion | 52.97 Million |
| Other Financing Activities | -1.83 Billion | -42.58 Million | -51.8 Million | -31.72 Million | -65.93 Million | 4.59 Billion |
| Accounts receivables | -211.49 Million | -64.62 Million | -201.98 Million | 7.43 Million | 41.79 Million | -275.29 Million |
| Accounts payables | - | 64.62 Million | 201.98 Million | -7.43 Million | -41.79 Million | - |
| Inventory | 614.09 Million | -711.69 Million | -129.2 Million | -283.82 Million | -638.96 Million | -141.47 Million |
| Other working capital | -436.25 Million | 143.56 Million | 800.32 Million | 578.47 Million | 872.9 Million | 409.47 Million |
| Cash at beginning of period | 9.23 Billion | 9.34 Billion | 7.25 Billion | 2.59 Billion | 280.37 Million | 508.41 Million |
| Cash at end of period | 3.49 Billion | 9.23 Billion | 9.34 Billion | 7.25 Billion | 2.59 Billion | 280.37 Million |
| Capital Expenditure | -22.78 Million | -5.92 Million | -15.11 Million | -17.55 Million | -13.51 Million | -6.1 Million |
| Effect of forex changes on cash | 36.78 Million | 283.44 Million | -148.89 Million | -313.05 Million | 56.79 Million | 62.8 Million |
| Net cash flow / Change in cash | -5.74 Billion | -104.57 Million | 2.08 Billion | 4.65 Billion | 2.31 Billion | -228.04 Million |
| Free Cash Flow | 1.05 Billion | 249.77 Million | 409.24 Million | 991.86 Million | 570.1 Million | 390.26 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 60.7 Million | 939.39 Million | 62.49 Million | 550.99 Million | 53.4 Million | 23.85 Million |
| Depreciation & Amortization | 3.94 Million | 53.68 Million | 3.53 Million | 63.71 Million | 3.98 Million | 5.32 Million |
| Deferred income taxes | - | - | - | 203.29 Million | - | - |
| Stock-based compensation | - | 266.05 Million | - | 308.89 Million | - | - |
| Change in working capital | -59.92 Million | -337.51 Million | 42.81 Million | -568.13 Million | -95.84 Million | 16.92 Million |
| Other non-cash items | 65.45 Million | -462.87 Million | 13.81 Million | -303.07 Million | 120.2 Million | 31.12 Million |
| Investing Cash Flow | -551.56 Million | -4.88 Billion | -141.25 Million | -532.43 Million | 26.69 Million | -109.73 Million |
| Investments in PPE | -848.48 Thousand | -22.78 Million | -2.31 Million | -5.92 Million | -138.94 Thousand | -709.28 Thousand |
| Acquisitions | 284.51 Thousand | -31.77 Million | -18.35 Million | -70.62 Million | 461.01 Thousand | -11.48 Million |
| Investment purchases | -608.97 Million | -5.36 Billion | -135.76 Million | -519.18 Million | 17.44 Million | -97.54 Million |
| Sales/Maturities of investments | 57.03 Million | 412.19 Million | 14.26 Million | 47.18 Million | 6.66 Million | - |
| Other Investing Activities | 938.56 Thousand | 13.39 Million | 919.07 Thousand | 16.11 Million | 2.26 Million | -2.00 |
| Financing Cash Flow | -270.78 Million | -1.98 Billion | -4.22 Million | -111.27 Million | -13.56 Million | -2.37 Million |
| Debt repayment | - | -39.93 Million | - | -42.58 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -12.6 Million | -104.56 Million | -1.9 Million | -81.58 Million | -11.68 Million | - |
| Common Stock Issuance | 97.83 Thousand | 878 Thousand | 23.96 Thousand | 12.89 Million | 631.61 Thousand | 1.21 Million |
| Other Financing Activities | -255.08 Million | -1.83 Billion | -2.34 Million | -42.58 Million | -2.5 Million | -3.59 Million |
| Accounts receivables | -25.4 Million | -211.49 Million | -3.93 Million | -64.62 Million | -6.66 Million | -2.59 Million |
| Accounts payables | -14.64 Million | - | -35.77 Million | 64.62 Million | -6.36 Million | 33.12 Million |
| Inventory | 28.66 Million | 614.09 Million | 56.52 Million | -711.69 Million | -86.18 Million | -15.79 Million |
| Other working capital | -48.54 Million | -436.25 Million | 25.99 Million | 143.56 Million | 3.36 Million | 2.19 Million |
| Cash at beginning of period | 1.29 Billion | 9.23 Billion | 1.36 Billion | 9.34 Billion | 1.6 Billion | 1.48 Billion |
| Cash at end of period | 521.42 Million | 3.49 Billion | 1.29 Billion | 9.23 Billion | 1.36 Billion | 1.6 Billion |
| Capital Expenditure | -848.48 Thousand | -22.78 Million | -2.31 Million | -5.92 Million | -138.94 Thousand | -709.28 Thousand |
| Effect of forex changes on cash | - | 36.78 Million | -55.44 Million | 283.44 Million | -223.54 Million | 150.03 Million |
| Net cash flow / Change in cash | -776.08 Million | -5.74 Billion | -68.51 Million | -104.57 Million | -235.84 Million | 119.22 Million |
| Free Cash Flow | 50.04 Million | 1.05 Billion | 130.09 Million | 249.77 Million | -25.56 Million | 80.58 Million |
OPXS
PCR
GAM
IMS
300632
MKPL